Skip to the page

Data / Form D filings / Petragen, Inc.

Petragen, Inc.: Form D filings

Petragen, Inc., a biotechnology company in Davie, FL, filed 3 Form D notices with the SEC between 2021 and 2026. The latest, on June 23, 2026, reports $495,000 sold of a $1 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
12555 Orange Drive, Suite 236, Davie, FL, 33330
Phone
(617) 302-6670
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1844157

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 23, 2026New notice$1,000,000$495,000$505,0009Apr 5, 2026sec.gov
Feb 16, 2022Amendment$5,000,000$1,882,307$3,117,69339Jan 22, 2021sec.gov
Feb 4, 2021New notice$5,000,000$650,726$4,349,27416Jan 22, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David KolbExecutive Officer, DirectorCEO and President
Demetrios Braddock, MD, PhDExecutive Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Jun 22, 2026 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Petragen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.